StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$11.04+0.06 (+0.55%)

Close on Nov 17, 2026Market cap $5.40BP/E –Yield –

Gossamer Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Gossamer Bio's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before. The highest annual figure on record is $29.08M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$12.43M-47.3%
FY2022Dec 31, 2022$23.60M-18.8%
FY2021Dec 31, 2021$29.08M+1.2%
FY2020Dec 31, 2020$28.74M+1.0%
FY2019Dec 31, 2019$28.46M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$9.59M-54.0%
Q4 FY2023Dec 31, 2023$12.43M-47.3%
Q3 FY2023Sep 30, 2023$15.25M-42.3%
Q2 FY2023Jun 30, 2023$18.05M-38.3%
Q1 FY2023Mar 31, 2023$20.83M-28.6%
Q4 FY2022Dec 31, 2022$23.60M-18.8%
Q3 FY2022Sep 30, 2022$26.45M-8.8%
Q2 FY2022Jun 30, 2022$29.26M+1.2%
Q1 FY2022Mar 31, 2022$29.17M+1.2%
Q4 FY2021Dec 31, 2021$29.08M+1.2%
Q3 FY2021Sep 30, 2021$28.99M+1.1%
Q2 FY2021Jun 30, 2021$28.91M+0.9%
Q1 FY2021Mar 31, 2021$28.82M+1.0%
Q4 FY2020Dec 31, 2020$28.74M+1.0%
Q3 FY2020Sep 30, 2020$28.67M+1.0%
Q2 FY2020Jun 30, 2020$28.64M+1.3%
Q1 FY2020Mar 31, 2020$28.55M–
Q4 FY2019Dec 31, 2019$28.46M–
Q3 FY2019Sep 30, 2019$28.37M–
Q2 FY2019Jun 30, 2019$28.28M–

More Gossamer Bio figures

See a number that looks wrong?